New Rochelle, NY, United States of America

Jason Koutcher


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jason Koutcher: Innovator in Cancer Treatment

Introduction

Jason Koutcher is a prominent inventor based in New Rochelle, NY (US). He has made significant contributions to the field of cancer research, particularly in developing innovative treatment strategies for drug-resistant cancer cells. With a total of 2 patents, Koutcher's work focuses on depleting cellular energy to combat cancer effectively.

Latest Patents

Koutcher's latest patents include groundbreaking inventions aimed at treating cancer. The first patent, titled "In-vivo energy depleting strategies for killing drug-resistant cancer cells," outlines a method for treating cancer subjects by administering a combination of ATP-depleting agents. This method targets cancer cells by reducing ATP levels to at least 15% of normal, utilizing agents such as mitochondrial ATP-inhibitors and methylthioadenosine phosphorylase inhibitors. The invention emphasizes the enhanced effectiveness of this treatment compared to compositions lacking these agents.

The second patent, "Treatment of cancer by reduction of intracellular energy and pyrimidines," also focuses on ATP depletion. This invention provides a method for treating cancer subjects by administering a combination of ATP-depleting agents, a pyrimidine antagonist, and an anticancer agent. The composition aims to deplete ATP levels in cancer cells while ensuring the treated cancer is sensitive to the anticancer agent.

Career Highlights

Koutcher is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research in cancer treatment. His work has garnered attention for its innovative approach to addressing drug resistance in cancer therapies.

Collaborations

Some of Koutcher's notable coworkers include Daniel S. Martin and Joseph R. Bertino, who contribute to the collaborative efforts in cancer research at the institute.

Conclusion

Jason Koutcher's innovative patents and research efforts represent a significant advancement in cancer treatment strategies. His focus on energy depletion in cancer cells offers promising avenues for overcoming drug resistance in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…